Search
for

    Sort by

    Research 121–150 of 141

    1. The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study JAAD Case Reports · 2025
    2. Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes Cureus · 2025
    3. Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system The Journal of Sexual Medicine · 2025
    4. Cancer-Related Alopecia Risk and Treatment Current Treatment Options in Oncology · 2025
    5. Spotlight commentary: Navigating the cutaneous side effects of chemotherapy British Journal of Clinical Pharmacology · 2025
    6. Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis BDJ Open · 2025
    7. The Impact of Androgenetic Alopecia on Ocular Health: An Investigation of Dry Eye and Meibomian Gland Dysfunction: Cross-Sectional Study Turkiye Klinikleri Journal of Ophthalmology · 2025
    8. Drugs and Androgenetic Alopecia: What to look out for 2024
    9. Bicalutamide: A review Journal of Cutaneous and Aesthetic Surgery · 2024
    10. From bench to babies – drug development for male subfertility Reproduction and Fertility · 2024
    11. Benefits of Testosterone Replacement and Methods of Substitution IntechOpen eBooks · 2023
    12. VIJAYA-The one who fights to win 2023
    13. Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update 2022
    14. Pharmacogenetics of the Androgen Metabolic Pathway 2010
    15. ZALCITABINE 2004
    16. Female pattern hair loss: therapeutic update Anais Brasileiros De Dermatologia · 2023
    17. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis BMC Medicine · 2014 · 122 citations
    18. Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know? Reviews in Endocrine and Metabolic Disorders · 2015 · 111 citations
    19. Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic? Reviews in endocrine and metabolic disorders · 2021 · 19 citations
    20. Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor Molecular and Cellular Endocrinology · 2006 · 17 citations
    21. ENZYMES British journal of pharmacology · 2011 · 1 citations
    22. Effectiveness of Anastrozole and Cyproterone Acetate in Two Brothers with Familial Male Precocious Puberty Journal of Pediatric Endocrinology and Metabolism · 2008 · 21 citations
    23. SUN-118 A Case of Anastrozole Induced Hyperandrogenism Journal of the Endocrine Society · 2025
    24. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents Annals of Oncology · 2005 · 67 citations
    25. Dihydrotestosterone, and Not Testosterone, Enhances the LPS-Induced Inflammatory Cytokine Gene Expression in Human Adipocytes Biomedicines · 2023 · 7 citations
    26. A Case of Familial Male-limited Precocious Puberty with a Novel Mutation JCRPE · 2020 · 6 citations
    27. Effects of Testosterone on the Expression of Connexin 26 and Connexin 43 in the Uterus of Rats During Early Pregnancy in Vivo · 2020 · 5 citations
    28. Daily subcutaneous testosterone for management of testosterone deficiency Frontiers in bioscience · 2018 · 3 citations
    29. Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database Frontiers in Pharmacology · 2025 · 2 citations
    30. Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network Expert Opinion on Drug Safety · 2024 · 1 citations